Integra Lifesciences Holdings (IART) Amortization of Deferred Charges (2009 - 2019)

Integra Lifesciences Holdings has disclosed Amortization of Deferred Charges across 11 years of filings, most recently posting $1.3 million for Q4 2019.

• In Q4 2019, Amortization of Deferred Charges fell 0.84% year-over-year to $1.3 million; the TTM figure through Dec 2019 stood at $5.4 million (down 14.04% YoY), while the FY2019 annual figure was $5.4 million, down 14.04% from the prior year.
• Amortization of Deferred Charges came in at $1.3 million for Q4 2019 at Integra Lifesciences Holdings, down from $1.4 million in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $2.1 million in Q2 2018 to a low of $387000.0 in Q3 2016.
• Average Amortization of Deferred Charges over 5 years is $958750.0, with a median of $763000.0 recorded in 2016.
• Year-over-year, Amortization of Deferred Charges slumped 36.94% in 2017 and soared 446.8% in 2018.
• Over 5 years, Amortization of Deferred Charges stood at $619000.0 in 2015, then soared by 46.37% to $906000.0 in 2016, then surged by 70.42% to $1.5 million in 2017, then decreased by 14.7% to $1.3 million in 2018, then declined by 0.84% to $1.3 million in 2019.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $1.3 million in Q4 2019, $1.4 million in Q3 2019, and $1.4 million in Q2 2019.